NON-COMPLEMENT-BINDING DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES AND KIDNEY ALLOGRAFT SURVIVAL

被引：0
|
作者：
Guidicelli, Gwendaline [1 ]
Guerville, Florent [1 ]
Lepreux, Sebastien [1 ]
Wiebe, Chris [2 ]
Thaunat, Olivier [3 ]
Duboiss, Valerie [4 ]
Visentin, Jonathan [1 ]
Bachelet, Thomas [1 ]
Morelon, Emmanuel [3 ]
Niderson, Peter [1 ]
Merville, Pierre [1 ]
Taupin, Jean-Luc [1 ]
Couzi, Lionel [1 ]
机构：
[1] CHU Bordeaux, Hop Pellegrin, Bordeaux, France
[2] Univ Manitoba, Winnipeg, MB R3T 2N2, Canada
[3] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France
[4] Etab Francais Sang Rhone Alpes, Lyon, France
来源：
TISSUE ANTIGENS | 2015年 / 85卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
O18
引用
收藏
页码：307 / 307
页数：1
相关论文
共 50 条
  • [41] IMPACT OF EVEROLIMUS ON DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Kitajima, Kumiko
    Nakajima, Ichiro
    Fuchinoue, Shohei
    TRANSPLANT INTERNATIONAL, 2013, 26 : 245 - 245
  • [42] Role of rituximab for isolated de novo donor specific anti-HLA antibodies in renal transplant recipients
    Schafer, Antonia
    Ferrai-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
  • [43] Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation
    Papachristou, M.
    Fylaktou, A.
    Daoudaki, M.
    Cholongitas, E.
    Karampatakis, T.
    Anastasiou, A.
    Chatzika, G.
    Makrovasili, F.
    Vagiotas, L.
    Karakasi, K.
    Fouzas, I.
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (02) : 424 - 428
  • [44] ROLE OF RITUXIMAB FOR ISOLATED DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Schafer, Antonia
    Hadaya, Karine
    Villard, Jean
    Ferrari-Lacrai, Sylvie
    HLA, 2020, 95 (04) : 322 - 322
  • [45] De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival
    Baudry, Guillaume
    Pozzi, Matteo
    Aubry, Matthieu
    Hugon-Vallet, Elisabeth
    Mocan, Raluca
    Chalabreysse, Lara
    Portran, Philippe
    Obadia, Jean-Francois
    Thaunat, Olivier
    Girerd, Nicolas
    Dubois, Valerie
    Sebbag, Laurent
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [46] Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
    de Sousa, Marcos Vinicius
    Goncalez, Ana Claudia
    Zollner, Ricardo de Lima
    Mazzali, Marilda
    ANNALS OF TRANSPLANTATION, 2018, 23 : 457 - 466
  • [47] Anti-HLA antibodies monitoring in kidney transplant recipients: high prevalence of donor specific anti-HLA class II antibodies
    Ares, O. M.
    Ruiz, A. T.
    Tagarro, E. F.
    Samper, R. G.
    Rodriguez, R. G.
    Palop, F. H.
    Valentin, M. A. P.
    Estupinan, R. S.
    Perez, J. C. R.
    Andres, M. D. C.
    IMMUNOLOGY, 2012, 137 : 736 - 737
  • [48] Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study
    Beland, Marc-Antoine
    Lapointe, Isabelle
    Noel, Real
    Cote, Isabelle
    Wagner, Eric
    Riopel, Julie
    Latulippe, Eva
    Desy, Olivier
    Beland, Stephanie
    Magee, Ciara N.
    Houde, Isabelle
    De Serres, Sacha A.
    TRANSPLANT INTERNATIONAL, 2017, 30 (05) : 502 - 509
  • [49] Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation
    Li, Xiaobei
    Ishida, Hideki
    Yamaguchi, Yutaka
    Tanabe, Kazunari
    TRANSPLANT INTERNATIONAL, 2008, 21 (12) : 1145 - 1152
  • [50] Characteristics and Clinical Significance of De Novo Donor-Specfic Anti-HLA Antibodies after Kidney Transplantation
    Jung, Hee-Yeon
    Kim, Su-Hee
    Seo, Min-Young
    Cho, Sun-Young
    Yang, Youngae
    Choi, Ji-Young
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Hyung-Kee
    Huh, Seung
    Won, Dong Il
    Kim, Chan-Duck
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (34)
12345